"","Adenocarcinoma","Age.at.diagnosis","ALK","antipd1","antipdl1","ARID1A","Asian","Black","BRAF","CDKN2A","dataset","Date.of.diagnosis","Date.of.irAE.1","early_irae","EGFR","ERBB2","Grade.of.irAE.1","Histology","I.O.for.irAE.1","Immunotherapy..1.End.Date","Immunotherapy..1.Start.Date","Immunotherapy.1_DrugName","Immunotherapy.Class","irae_cat","irae_cat_1yr","irae_cat_6mo","irae_pos","irae_pos_1yr","irae_pos_6mo","irAE.1","irAE.1_EarlyLate","irAE.1_pos_neg","irAE.1.category","KRAS","Last.Visit","Line.of.immunotherapy..1","Line.of.therapy.TKI..1","LRP1B","male","MET","Molecular.test.performed","os_1yr_flag_surv","os_days_update","Packyear","PD..date..1","PD.Date.TKI..1","PD.L1.Range","PD.L1.Status","pdl1_149","pdl1_50100","pdl1_neg","pfs_6months_flag_surv","pfs_days","pfs_flag","PIK3CA","prior_tki","priortki","Race","Report.Date","Sex","SHADOW.ID","SMARCA4","Smoking","Squamous","Stage","StageIII","StageIorII","StageIV","STK11","survival_flag","TKI..1.Drug.Name","TKI..1.End.date","TKI..1.Start.date","TP53","VitalStatus","White"
"1",1,73,"",1,0,"",0,0,"","","NON-TKI",17913,18018,1,"","",NA,"adenocarcinoma",NA,18032,18004,"Nivolumab","anti-pd-1",1,1,1,0,0,0,"infusion reaction: sob, desaturation, htn, chills, tachycardia","Early irAE","positive","Respiratory","G12C",18175,2,NA,"",1,"","OncoComplete",0,171,120,18046,NA,"Not Reported","",0,0,0,0,42,1,"","No Prior TKI",0,"White",18044,1,"AK03181U","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"2",0,80,"",0,1,"",1,0,"","","NON-TKI",18453,NA,0,"","",NA,"squamous",NA,19013,18621,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19277,2,NA,"",1,"","OncoComplete",1,656,30,19034,NA,"Not Reported","Not Reported",0,0,0,1,413,1,"","No Prior TKI",0,"Asian",18488,1,"AK32849P","",1,1,"IV",0,0,1,"",0,"",NA,NA,"","Alive",0
"3",1,52,"",1,0,"",0,0,"","","TKI",18037,18732,0,"E746_A750del","",NA,"adenocarcinoma",NA,18705,18311,"Nivolumab","anti-pd-1",0,0,0,1,0,0,"acute renal failure","Late irAE","positive","IRAE","",18732,2,3,"",0,"","Foundation ACT",1,421,NA,18732,18688,"Not Reported","Not Reported",0,0,0,1,421,1,"","No Prior TKI",0,"Unknown or Other",18309,0,"AK40469X","",1,0,"IV",0,0,1,"",0,"osimertinib",18688,18611,"","Alive",0
"4",1,68,"",1,0,"",0,0,"","p16INK4a D108Y, p14ARF R122L","NON-TKI",18396,NA,0,"amplification","",NA,"adenocarcinoma",NA,18479,18479,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18493,1,NA,"",0,"","FoundationOne",0,14,50,18493,NA,">=50%","90%",0,1,0,0,14,1,"","No Prior TKI",0,"White",18471,0,"AK50895Z","",1,0,"IV",0,0,1,"",1,"",NA,NA,"R156G","Deceased",1
"5",1,69,"",1,0,"",0,0,"","","TKI",15964,NA,0,"E746_A750del, T790M","",NA,"adenocarcinoma",NA,18045,17954,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18181,5,1,"",0,"","Onco48",0,227,25,18059,17142,"Not Reported","Not Reported",0,0,0,0,105,1,"","Prior TKI",1,"White",17317,0,"AM05028X","",1,0,"IV",0,0,1,"",1,"erlotinib",17142,15945,"","Deceased",1
"6",1,60,"",0,1,"",0,0,"","","NON-TKI",17199,NA,0,"","",NA,"adenocarcinoma",NA,18913,18556,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19138,2,NA,"",1,"","Foundation",1,582,10,18913,NA,"1-49%","1%",1,0,0,1,357,1,"","No Prior TKI",0,"White",19087,1,"AN02340S","",1,0,"IV",0,0,1,"",0,"",NA,NA,"R282W","Alive",1
"7",1,51,"",0,1,"",0,1,"negative","","NON-TKI",18022,NA,0,"negative","",NA,"adenocarcinoma",NA,19150,18520,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","negative",19296,2,NA,"",0,"","Paradigm ",1,776,15,19170,NA,"Not Reported","",0,0,0,1,650,1,"","No Prior TKI",0,"Black or African American",18134,0,"AN35486R","",1,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",0
"8",1,66,"",1,0,"",1,0,"","","NON-TKI",18491,NA,0,"","",NA,"adenocarcinoma",NA,18614,18572,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","G12R",19025,1,NA,"",1,"","HopeSeq",1,453,40,18640,NA,">=50%","90%",0,1,0,0,68,1,"","No Prior TKI",0,"Asian",18564,1,"AN86077W","",1,0,"IV",0,0,1,"",1,"",NA,NA,"Y205C","Deceased",0
"9",1,77,"",1,0,"",0,0,"","","NON-TKI",18710,18723,1,"","",4,"adenocarcinoma",NA,18869,18722,"Pembrolizumab","anti-pd-1",0,0,0,1,1,1,"fatigue","Early irAE","positive","IRAE","",18885,1,NA,"",0,"","Paradigm  (ALK, ROS1: Neg, EGFR: Ins Spec.)",0,163,78,18885,NA,">=50%","90%",0,1,0,0,163,1,"","No Prior TKI",0,"White",18702,0,"AN88592U","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"10",1,67,"rearrangement intron 19",1,0,"P239A (VUS)",0,0,"","2","TKI",17911,NA,0,"","",NA,"adenocarcinoma",NA,18243,18201,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18253,3,1,"",1,"S794P (VUS)","Foundation",0,52,NA,18253,18003,"1-49%","5%",1,0,0,0,52,1,"","Prior TKI",1,"White",18164,1,"BJ41053Y","loss exons 31-35",0,0,"IV",0,0,1,"loss exons 7-10, rearrangement (VUS)",1,"crizotinib",18003,17934,"","Deceased",1
"11",1,66,"V1405L (VUS)",1,0,"",0,0,"","","NON-TKI",17862,17996,1,"","",1,"adenocarcinoma",NA,18165,17982,"Nivolumab","anti-pd-1",0,0,0,1,1,1,"hyponatremia","Early irAE","positive","IRAE","G12C",18418,1,NA,"",0,"A347T (VUS)","Foundation",1,436,50,18176,NA,"Negative","Negative",0,0,1,1,194,1,"","No Prior TKI",0,"White",17925,0,"BJ81291Y","P169fs*134",1,0,"IV",0,0,1,"E165*",1,"",NA,NA,"","Deceased",1
"12",1,76,"",0,1,"",1,0,"","","NON-TKI",17969,18400,0,"","",NA,"adenocarcinoma",NA,19031,18313,"Atezolizumab","anti-pd-l1",1,1,1,0,0,0,"hypothyroidism","Late irAE","positive","Endocrine","",19276,2,NA,"",1,"","ONCOMUTATIONS",1,963,13,19052,NA,"Not Reported","",0,0,0,1,739,1,"","No Prior TKI",0,"Asian",18024,1,"BJ89714Q","",1,0,"IV",0,0,1,"Y36Ffs*16",0,"",NA,NA,"","Alive",0
"13",1,54,"",1,0,"",0,0,"","","NON-TKI",18626,NA,0,"","",NA,"adenocarcinoma",NA,18869,18673,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19158,1,NA,"",1,"","Cedars Comprehensive Cancer Panel",1,485,31.5,18935,NA,"Not Reported","Not Reported",0,0,0,1,262,1,"","No Prior TKI",0,"Unknown or Other",19080,1,"BK02431X","",1,0,"IV",0,0,1,"",1,"",NA,NA,"V143G","Deceased",0
"14",1,64,"",0,1,"",0,0,"","","NON-TKI",18568,18815,0,"","",2,"adenocarcinoma",NA,18801,18703,"Durvalumab","anti-pd-l1",1,1,1,0,0,0,"pneumonitis","Late irAE","positive","Respiratory","p.G12C, c.34G>T",19186,2,NA,"",1,"","HopeSeq",1,483,40,18815,NA,"1-49%","35%",1,0,0,0,112,1,"","No Prior TKI",0,"White",18607,1,"BL12750Z","",1,0,"III",1,0,0,"",0,"",NA,NA,"","Alive",1
"15",1,66,"",1,0,"",0,0,"","","NON-TKI",18659,NA,0,"","",NA,"adenocarcinoma",NA,18767,18711,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","G12V",18793,1,NA,"",1,"","Guardant360",0,82,22.5,NA,NA,"Negative","Negative",0,0,1,1,NA,0,"","No Prior TKI",0,"Unknown or Other",18721,1,"BN46666W","",1,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",0
"16",1,62,"",1,0,"",0,0,"","","NON-TKI",18254,18408,0,"","",NA,"adenocarcinoma",NA,18388,18281,"Pembrolizumab","anti-pd-1",1,1,1,0,0,0,"colitis","Late irAE","positive","Gastrointestinal","G12R",19305,1,NA,"",1,"","GEMExtra",1,1024,30,18407,NA,">=50%","50%",0,1,0,0,126,1,"","No Prior TKI",0,"White",19243,1,"BN83404P","",1,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",1
"17",1,81,"",1,0,"",0,0,"","","NON-TKI",18619,18723,1,"","",2,"adenocarcinoma",NA,19152,18718,"Pembrolizumab","anti-pd-1",1,1,1,0,0,0,"rash","Early irAE","positive","Skin","G12C",19310,1,NA,"",0,"","HopeSeq",1,592,60,19152,NA,">=50%","80%",0,1,0,1,434,1,"","No Prior TKI",0,"Unknown or Other",18691,0,"CJ01823V","",1,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",0
"18",0,58,"",1,0,"",0,0,"","","NON-TKI",16157,18668,1,"","",NA,"squamous",NA,18843,18647,"Pembrolizumab","anti-pd-1",0,0,0,1,1,1,"mild anemia","Early irAE","positive","IRAE","",18845,1,NA,"",1,"","Paradigm (ALK, ROS1)",0,198,NA,18845,NA,"Negative","Negative",0,0,1,1,198,1,"","No Prior TKI",0,"Unknown or Other",18670,1,"CJ70673T","",0,1,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",0
"19",1,56,"negative",1,0,"",0,0,"","","NON-TKI",18015,18506,0,"negative","",NA,"adenocarcinoma",NA,18534,18093,"Nivolumab","anti-pd-1",0,0,0,1,0,0,"arthralgia","Late irAE","positive","IRAE","",18709,2,NA,"",1,"","Huntington Hospital molecular analysis (ALK, ROS1, EGFR)",1,616,40,18540,NA,"Not Reported","",0,0,0,1,447,1,"","No Prior TKI",0,"White",18026,1,"CJ71910X","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"20",1,74,"",0,1,"",0,0,"","","NON-TKI",18227,NA,0,"","",NA,"adenocarcinoma",NA,18397,18332,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18457,2,NA,"A1260G (VUS)",1,"","Foundation",0,125,30,18418,NA,"1-49%","30%",1,0,0,0,86,1,"E545K","No Prior TKI",0,"White",18214,1,"CJ86013R","",1,0,"IV",0,0,1,"",1,"",NA,NA,"P151R","Deceased",1
"21",1,61,"",1,0,"",0,0,"","","NON-TKI",18639,18830,0,"","",1,"adenocarcinoma",NA,19213,18669,"Pembrolizumab","anti-pd-1",0,0,0,1,1,1,"fatigue","Late irAE","positive","IRAE","G12C",19304,1,NA,"",1,"","LabCorp (KRAS, EGFR, ALK)",1,635,80,NA,NA,">=50%","90%",0,1,0,1,NA,0,"","No Prior TKI",0,"White",18659,1,"CL21089P","",1,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",1
"22",1,63,"",1,0,"",0,0,"","","NON-TKI",17603,NA,0,"","",NA,"adenocarcinoma",NA,17751,17737,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","G12V",17775,2,NA,"",1,"","Foundation",0,38,NA,17775,NA,"Not Reported","Not Reported",0,0,0,0,38,1,"","No Prior TKI",0,"White",18045,1,"CL42993U","",0,0,"IV",0,0,1,"",1,"",NA,NA,"R273L","Deceased",1
"23",1,53,"",1,0,"",0,0,"","","NON-TKI",18556,18604,1,"","",NA,"adenocarcinoma",NA,19041,18603,"Pembrolizumab","anti-pd-1",0,0,0,1,1,1,"headaches","Early irAE","positive","IRAE","G12C",19293,1,NA,"H3992D (VUS), P1735T (VUS)",0,"","Foundation",1,690,7,NA,NA,">=50%","50%",0,1,0,1,NA,0,"","No Prior TKI",0,"Unknown or Other",18589,0,"CL67952S","",1,0,"IV",0,0,1,"truncation exon 4",0,"",NA,NA,"","Alive",0
"24",1,65,"",0,1,"",1,0,"","","NON-TKI",18353,NA,0,"","",NA,"adenocarcinoma",NA,18421,18400,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","G12V",19138,1,NA,"",1,"","HopeSeq",1,738,25,18488,NA,"1-49%","1%",1,0,0,0,88,1,"","No Prior TKI",0,"Asian",18648,1,"CL77438S","P1527S (VUS)",1,0,"III",1,0,0,"E199*",0,"",NA,NA,"","Alive",0
"25",1,64,"",1,0,"",0,0,"","","TKI",16552,17877,1,"E746_A750del, T790M","",NA,"adenocarcinoma",NA,17891,17828,"Nivolumab","anti-pd-1",0,0,0,1,1,1,"joint pain","Early irAE","positive","IRAE","",17964,5,2,"",0,"","Onco48",0,136,NA,17905,17158,"Not Reported","Not Reported",0,0,0,0,77,1,"","Prior TKI",1,"White",17344,0,"CM00092X","",0,0,"IV",0,0,1,"",0,"erlotinib",17158,16673,"A276G","Alive",1
"26",1,68,"negative",1,0,"",0,0,"","","NON-TKI",18038,NA,0,"negative","",NA,"adenocarcinoma",NA,18726,18386,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19247,2,NA,"",0,"","Genoptix (EGFR, ALK)",1,861,20,18729,NA,">=50%","80%",0,1,0,1,343,1,"","No Prior TKI",0,"White",18060,0,"CM05463W","",1,0,"No Staging Data",0,0,0,"",0,"",NA,NA,"","Alive",1
"27",0,71,"",1,0,"",1,0,"","","NON-TKI",17877,NA,0,"negative","",NA,"squamous",NA,17975,17975,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","negative",17991,2,NA,"",1,"","Cancer Hotspot Genotyping",0,16,NA,17980,NA,"Not Reported","",0,0,0,0,5,1,"","No Prior TKI",0,"Asian",17896,1,"CM09112V","",0,1,"IV",0,0,1,"",1,"",NA,NA,"R342* (VUS)","Deceased",0
"28",0,73,"",1,0,"G277fs",0,0,"","","NON-TKI",17788,NA,0,"","",NA,"squamous",NA,18816,17975,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18932,2,NA,"",1,"","Guardant360",1,957,NA,18849,NA,"Not Reported","Not Reported",0,0,0,1,874,1,"","No Prior TKI",0,"White",18931,1,"CM62999V","",1,1,"III",1,0,0,"",0,"",NA,NA,"Splice site SNV","Alive",1
"29",0,65,"",1,0,"",1,0,"","loss","NON-TKI",17709,17854,1,"","",2,"squamous",NA,17994,17840,"Nivolumab","anti-pd-1",1,1,1,0,0,0,"diarrhea","Early irAE","positive","Gastrointestinal","",18502,2,NA,"G1951R (VUS)",1,"","Foundation",1,662,7.5,18003,NA,"Not Reported","",0,0,0,0,163,1,"","No Prior TKI",0,"Asian",17754,1,"DK22678X","",1,1,"IV",0,0,1,"",0,"",NA,NA,"","Alive",0
"30",1,82,"",0,1,"P1175L (VUS)",0,0,"","","TKI",17977,NA,0,"E746_A750del","",NA,"adenocarcinoma",NA,18765,18732,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18998,4,1,"",0,"","Foundation",0,266,NA,18787,18291,"Not Reported","Not Reported",0,0,0,0,55,1,"","Prior TKI",1,"White",18030,0,"DL13440W","",0,0,"IV",0,0,1,"",1,"afatinib",18291,18039,"R248Q","Deceased",1
"31",1,76,"",1,0,"",1,0,"","","NON-TKI",17023,17967,0,"A767_S768insTLA","",NA,"adenocarcinoma",NA,17911,17897,"Nivolumab","anti-pd-1",0,0,0,1,1,1,"azotemia","Late irAE","positive","IRAE","",18477,3,NA,"",0,"","Onco48",1,580,NA,17981,NA,"Not Reported","Not Reported",0,0,0,0,84,1,"","No Prior TKI",0,"Asian",18010,0,"DL14688U","",0,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",0
"32",0,74,"",0,1,"",0,0,"","","NON-TKI",18341,NA,0,"","",NA,"squamous",NA,18411,18369,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18635,2,NA,"",1,"","OncoComplete",0,266,136,18423,NA,"Negative","Negative",0,0,1,0,54,1,"","No Prior TKI",0,"White",18337,1,"DL65808X","",1,1,"I or II",0,1,0,"",1,"",NA,NA,"C176F","Deceased",1
"33",1,47,"",1,0,"",0,0,"","","NON-TKI",18318,NA,0,"","",NA,"adenocarcinoma",NA,18436,18374,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19062,1,NA,"",0,"","OncoComplete",1,688,10,18447,NA,">=50%","100%",0,1,0,0,73,1,"","No Prior TKI",0,"White",18339,0,"DL82708X","",1,0,"IV",0,0,1,"",1,"",NA,NA,"E285K","Deceased",1
"34",1,74,"",1,0,"",0,0,"","","NON-TKI",18497,NA,0,"","",NA,"adenocarcinoma",NA,18871,18703,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18932,2,NA,"",1,"","NeoGenomics (BRAF, ALK)",0,229,40,18871,NA,"1-49%","30%",1,0,0,0,168,1,"","No Prior TKI",0,"White",18466,1,"DM57805Y","",1,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",1
"35",0,67,"",1,0,"",0,0,"","","NON-TKI",18222,18424,0,"","",NA,"squamous",NA,18508,18354,"Pembrolizumab","anti-pd-1",1,1,1,0,0,0,"pneumonitis","Late irAE","positive","Respiratory","",18681,1,NA,"duplication exons 55-66",0,"","Foundation",0,327,75,18529,NA,"Negative","Negative",0,0,1,0,175,1,"","No Prior TKI",0,"White",18601,0,"DN29052S","E1252*",1,1,"IV",0,0,1,"",1,"",NA,NA,"Y234C","Deceased",1
"36",1,66,"",1,0,"",0,0,"","","NON-TKI",18387,NA,0,"","",NA,"adenocarcinoma",NA,18582,18449,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18643,1,NA,"",0,"","Foundation",0,194,10,18643,NA,">=50%","50%",0,1,0,1,194,1,"","No Prior TKI",0,"White",18411,0,"DN46202S","",1,0,"IV",0,0,1,"",1,"",NA,NA,"C242S","Deceased",1
"37",1,76,"",1,0,"S90fs*11-subclonal",0,0,"","p16INK4aS12*","NON-TKI",18187,18341,1,"","",NA,"adenocarcinoma",NA,18704,18340,"Nivolumab","anti-pd-1",0,0,0,1,1,1,"chills","Early irAE","positive","IRAE","",19271,2,NA,"",0,"","Foundation",1,931,NA,18716,NA,">=50%","70%",0,1,0,1,376,1,"","No Prior TKI",0,"White",18740,0,"DN55697R","",1,0,"IV",0,0,1,"",1,"",NA,NA,"E285K, G2455, R273H subclonal, S183*","Deceased",1
"38",1,81,"Negative",1,0,"",0,0,"","","NON-TKI",17774,18017,1,"Negative","",1,"adenocarcinoma",NA,18017,17961,"Nivolumab","anti-pd-1",0,0,0,1,1,1,"fatigue","Early irAE","positive","IRAE","Negative",18067,2,NA,"",0,"","OSH EGFR KRAS ALK ROS1 (All Negative)",0,106,NA,18043,NA,">=50%","60%",0,1,0,0,82,1,"","No Prior TKI",0,"White",17787,0,"DN83370Q","",0,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"39",1,63,"",0,1,"",0,0,"","","NON-TKI",18576,NA,0,"A822T (VUS), R986K (VUS)","",NA,"adenocarcinoma",NA,18733,18687,"Durvalumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18753,1,NA,"",0,"","FoundationACT",0,66,20,18739,NA,"Not Reported","Not Reported",0,0,0,0,52,1,"","No Prior TKI",0,"Unknown or Other",18663,0,"EJ77564Y","",1,0,"III",1,0,0,"",1,"",NA,NA,"","Deceased",0
"40",0,78,"",1,0,"",0,0,"","Loss","NON-TKI",18418,18715,0,"","",NA,"squamous",NA,18673,18449,"Pembrolizumab","anti-pd-1",0,0,0,1,1,0,"severe arthralgias and myalgias","Late irAE","positive","IRAE","",19307,1,NA,"",1,"","Foundation",1,858,23.5,18715,NA,"1-49%","10%",1,0,0,1,266,1,"E542K","No Prior TKI",0,"White",19844,1,"EK68082V","",1,1,"IV",0,0,1,"",0,"",NA,NA,"S215I","Alive",1
"41",1,54,"",1,0,"Q944*",0,0,"","","NON-TKI",18701,18940,0,"","",2,"adenocarcinoma",NA,18961,18736,"Pembrolizumab","anti-pd-1",0,0,0,1,1,0,"fatigue","Late irAE","positive","IRAE","G12D",19115,1,NA,"",0,"","Foundation",1,379,NA,18984,NA,"Negative","Negative",0,0,1,1,248,1,"","No Prior TKI",0,"White",18732,0,"EL79542P","",0,0,"III",1,0,0,"",1,"",NA,NA,"","Deceased",1
"42",0,67,"",0,1,"",0,0,"","","NON-TKI",18463,NA,0,"","",NA,"squamous",NA,18782,18740,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19074,2,NA,"",1,"","Foundation",0,334,NA,18795,NA,"1-49%","10%",1,0,0,0,55,1,"","No Prior TKI",0,"Unknown or Other",18842,1,"EM24239S","",1,1,"IV",0,0,1,"",1,"",NA,NA,"H168L","Deceased",0
"43",1,69,"",1,0,"",0,0,"","","TKI",17170,NA,0,"L858R","",NA,"adenocarcinoma",NA,18724,18627,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18782,3,2,"",0,"","NeoGenomics EGFR",0,155,15,18737,18583,"Not Reported","Not Reported",0,0,0,0,110,1,"","Prior TKI",1,"Unknown or Other",18562,0,"EM24682R","",1,0,"III",1,0,0,"",1,"erlotinib",18585,18030,"","Deceased",0
"44",1,83,"I964N (VUS)",1,0,"",0,0,"","p16INK4a R58*, p14ARF P72L","NON-TKI",18473,18997,0,"","",NA,"adenocarcinoma",NA,NA,18638,"Pembrolizumab","anti-pd-1",1,1,0,0,0,0,"pruritus","Late irAE","positive","Skin","",19265,1,NA,"I1757V (VUS), L1894V (VUS)",1,"","Foundation",1,627,60,NA,NA,"Negative","Negative",0,0,1,1,NA,0,"E545K","No Prior TKI",0,"Unknown or Other",18617,1,"EM73051P","",1,0,"IV",0,0,1,"",0,"",NA,NA,"splice site 673-1G>A","Alive",0
"45",1,66,"",1,0,"",0,0,"","","NON-TKI",18514,18640,1,"","",2,"adenocarcinoma",NA,18668,18583,"Nivolumab","anti-pd-1",1,1,1,0,0,0,"cough and dyspnea","Early irAE","positive","Respiratory","G12A",18727,3,NA,"",0,"","Genoptix (ALK, BRAF, CD274, EGFR, ERBB2, KRAS, MET, RET, ROS1)",0,144,10,18727,NA,">=50%","85%",0,1,0,0,144,1,"","No Prior TKI",0,"White",18538,0,"EM84877X","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"46",1,86,"",1,0,"",0,0,"","","NON-TKI",18109,NA,0,"","",NA,"adenocarcinoma",NA,18460,18397,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18530,2,NA,"",1,"","Foundation",0,133,60,18479,NA,"1-49%","5%",1,0,0,0,82,1,"","No Prior TKI",0,"White",18388,1,"EN86741S","",1,0,"I or II",0,1,0,"",0,"",NA,NA,"W53*","Alive",1
"47",1,80,"",1,0,"",0,0,"","","NON-TKI",18698,NA,0,"","",NA,"adenocarcinoma",NA,18745,18745,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18758,1,NA,"",1,"","Foundation",0,13,93,18758,NA,"Negative","Negative",0,0,1,0,13,1,"","No Prior TKI",0,"White",18735,1,"FK48168U","",1,0,"III",1,0,0,"",1,"",NA,NA,"Q192*","Deceased",1
"48",1,81,"",1,0,"",0,0,"","","NON-TKI",16331,NA,0,"","",NA,"adenocarcinoma",NA,17988,17946,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18002,2,NA,"",1,"","Onco48",0,56,50,18002,NA,"Not Reported","Not Reported",0,0,0,0,56,1,"1633G>A E545K","No Prior TKI",0,"White",17351,1,"FM86208W","",1,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",1
"49",1,76,"",1,0,"",0,0,"","","TKI",17954,18540,1,"E746_A750del","",NA,"adenocarcinoma",NA,18540,18540,"Pembrolizumab","anti-pd-1",0,0,0,1,1,1,"neutropenic fever and mucositis","Early irAE","positive","IRAE","",18572,3,1,"",0,"","OncoComplete",0,32,NA,18540,18399,">=50%","100%",0,1,0,0,0,1,"","Prior TKI",1,"White",18429,0,"FN23096T","",0,0,"IV",0,0,1,"",1,"afatinib",18399,17954,"Splice Site 376-2A>G","Deceased",1
"50",1,60,"",0,1,"",1,0,"","","TKI",17437,18247,1,"E746_A750del, T790M","",NA,"adenocarcinoma",NA,18270,18226,"Atezolizumab","anti-pd-l1",0,0,0,1,1,1,"stomatitis","Early irAE","positive","IRAE","",18419,4,1,"",0,"","Onco48",0,193,NA,18289,17822,">=50%","80%",0,1,0,0,63,1,"","Prior TKI",1,"Asian",17849,0,"GJ57993X","",0,0,"IV",0,0,1,"",1,"afatinib",17680,17496,"R273L","Deceased",0
"51",1,75,"",1,0,"",0,0,"","","NON-TKI",17690,18113,1,"","",2,"adenocarcinoma",NA,18155,18085,"Nivolumab","anti-pd-1",1,1,1,0,0,0,"constipation","Early irAE","positive","Gastrointestinal","G12C",18190,3,NA,"",0,"","OncoMutations",0,105,5,18171,NA,"Not Reported","",0,0,0,0,86,1,"","No Prior TKI",0,"White",18131,0,"GJ59578Q","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"52",1,34,"",0,1,"G987fs*45",1,0,"","","TKI",17771,NA,0,"amplification, L858R","amplification",NA,"adenocarcinoma",NA,18166,18166,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18281,5,2,"H2341Y (VUS)",0,"amplification, G87V (VUS)","Foundation",0,115,NA,18179,17927,"Not Reported","Not Reported",0,0,0,0,13,1,"","Prior TKI",1,"Asian",18206,0,"GL10472S","",0,0,"IV",0,0,1,"",0,"crizotinib",17927,17899,"E258V","Alive",0
"53",1,79,"",1,0,"",0,0,"","","NON-TKI",17923,18155,1,"","",1,"adenocarcinoma",NA,18212,18109,"Nivolumab","anti-pd-1",1,1,1,0,0,0,"constipation","Early irAE","positive","Gastrointestinal","G12C",18286,2,NA,"",1,"","Foundation",0,177,120,18222,NA,"Not Reported","",0,0,0,0,113,1,"","No Prior TKI",0,"White",18225,1,"GL54366X","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"54",1,76,"negative",0,1,"",0,0,"negative","","NON-TKI",18457,NA,0,"negative","",NA,"adenocarcinoma",NA,18640,18640,"Durvalumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","negative",18663,2,NA,"",0,"","NeoGenomics",0,23,6,18645,NA,"Not Reported","Not Reported",0,0,0,0,5,1,"","No Prior TKI",0,"White",18472,0,"GL83918X","",1,0,"III",1,0,0,"",1,"",NA,NA,"","Deceased",1
"55",1,57,"",0,1,"",0,0,"","loss","NON-TKI",18135,NA,0,"","",NA,"adenocarcinoma",NA,18290,18269,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","G12C",18395,2,NA,"K3712T, L1205I (VUS)",1,"","Foundation",0,126,60,18299,NA,"Negative","Negative",0,0,1,0,30,1,"","No Prior TKI",0,"White",18222,1,"GM27441R","loss exons 12-29",1,0,"IV",0,0,1,"G242V",1,"",NA,NA,"","Deceased",1
"56",1,68,"rearrangment",1,0,"",0,0,"","","TKI",16349,18180,1,"","",NA,"adenocarcinoma",NA,18152,18138,"Nivolumab","anti-pd-1",1,1,1,0,0,0,"pneumonitis","Early irAE","positive","Respiratory","",18324,7,2,"",1,"","COH panel (EGFR, KRAS), ALK FISH",0,186,3,18187,17662,"Not Reported","Not Reported",0,0,0,0,49,1,"","Prior TKI",1,"White",16400,1,"GM70167V","",1,0,"IV",0,0,1,"",1,"crizotinib",17662,16462,"","Deceased",1
"57",1,80,"negative",1,0,"",0,0,"","","NON-TKI",18379,NA,0,"negative","",NA,"adenocarcinoma",NA,18796,18586,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18815,2,NA,"",0,"","Integrated Oncology (EGFR, ALK)",0,229,60,18815,NA,"1-49%","30%",1,0,0,1,229,1,"","No Prior TKI",0,"Unknown or Other",18344,0,"GM79544Y","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",0
"58",0,69,"",1,0,"",0,0,"","","NON-TKI",18682,NA,0,"","",NA,"squamous",NA,18731,18731,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18747,1,NA,"",1,"","Foundation Medicine (PD-L1 Only)",0,16,25,18747,NA,"1-49%","1%",1,0,0,0,16,1,"","No Prior TKI",0,"White",18692,1,"GM84101Q","",1,1,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"59",1,62,"",1,0,"",0,0,"","","NON-TKI",18010,18505,1,"","",NA,"adenocarcinoma",NA,18662,18464,"Nivolumab","anti-pd-1",1,1,1,0,0,0,"diarrhea","Early irAE","positive","Gastrointestinal","G12C",18763,2,NA,"",0,"","Guardant360",0,299,NA,18689,NA,"Not Reported","Not Reported",0,0,0,1,225,1,"","No Prior TKI",0,"Unknown or Other",18531,0,"GN66217T","",0,0,"IV",0,0,1,"",1,"",NA,NA,"R273C, D281E, L194F, C238G, S116C, I232S","Deceased",0
"60",1,66,"",1,0,"",0,0,"","p.W110*, c.330G>A","NON-TKI",18675,NA,0,"","",NA,"adenocarcinoma",NA,19060,18690,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","pG12D, c.35G>A",19275,2,NA,"",0,"","HopeSeq",1,585,50,19069,NA,"Not Reported","Not Reported",0,0,0,1,379,1,"","No Prior TKI",0,"Unknown or Other",18698,0,"GN76133Q","",1,0,"IV",0,0,1,"p.K44*, c.595G>T",0,"",NA,NA,"","Alive",0
"61",1,74,"",1,0,"",0,0,"","A76fs","NON-TKI",18150,NA,0,"","E1192D",NA,"adenocarcinoma",NA,18359,18332,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18369,2,NA,"",1,"","Guardant360",0,37,20,18365,NA,"Negative","Negative",0,0,1,0,33,1,"","No Prior TKI",0,"White",18321,1,"HJ44618U","",1,0,"IV",0,0,1,"S216F",1,"",NA,NA,"Y220C, H179D, G244S","Deceased",1
"62",0,56,"",1,0,"",0,0,"","","NON-TKI",18068,NA,0,"","",NA,"large cell or nos nslc",NA,18758,18716,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18947,2,NA,"",1,"","HopeSeq",0,231,45,18775,NA,"1-49%","30%",1,0,0,0,59,1,"","No Prior TKI",0,"White",18660,1,"HL90550U","",1,0,"IV",0,0,1,"",1,"",NA,NA,"p.Q317*, c.949C>T","Deceased",1
"63",1,60,"",1,0,"",0,0,"","","TKI",16272,NA,0,"","G776_V777>VCV",NA,"adenocarcinoma",NA,17891,17821,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",17917,8,3,"",1,"","Foundation",0,96,NA,17903,17954,"Not Reported","Not Reported",0,0,0,0,82,1,"","Prior TKI",1,"White",16846,1,"HL92064X","",0,0,"IV",0,0,1,"",1,"erlotinib",17954,16766,"","Deceased",1
"64",1,70,"",0,1,"",1,0,"","","NON-TKI",17711,NA,0,"","Y772_A775dup",NA,"adenocarcinoma",NA,18473,18431,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18768,1,NA,"",0,"","Onco48",0,337,NA,18492,NA,"Not Reported","Not Reported",0,0,0,0,61,1,"","No Prior TKI",0,"Asian",17731,0,"HM86685Z","",0,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",0
"65",1,78,"",1,0,"",0,0,"","","NON-TKI",17984,NA,0,"","",NA,"adenocarcinoma",NA,18080,18065,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18144,3,NA,"",1,"","No Report",0,79,90,18144,NA,"Not Reported","",0,0,0,0,79,1,"","No Prior TKI",0,"White",NA,1,"AK54502U","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"66",1,69,"",0,1,"",0,0,"","","NON-TKI",18463,18738,0,"","",NA,"adenocarcinoma",NA,18893,18642,"Durvalumab","anti-pd-l1",0,0,0,1,1,1,"normochromic normocytic anemia","Late irAE","positive","IRAE","",19307,2,NA,"",0,"","No Report",1,665,NA,18899,NA,"Negative","Negative",0,0,1,1,257,1,"","No Prior TKI",0,"Unknown or Other",NA,0,"AM14952X","",0,0,"III",1,0,0,"",0,"",NA,NA,"","Alive",0
"67",0,66,"",1,0,"",0,0,"","","NON-TKI",17088,17645,0,"","",NA,"squamous",NA,18080,17561,"Nivolumab","anti-pd-1",1,1,1,0,0,0,"elevated lfts","Late irAE","positive","Endocrine","",18235,2,NA,"",1,"","No Report",1,674,20,18094,NA,"Not Reported","Not Reported",0,0,0,1,533,1,"","No Prior TKI",0,"White",NA,1,"CM22404T","",1,1,"IV",0,0,1,"",0,"",NA,NA,"","Alive",1
"68",1,71,"",1,0,"",0,0,"","","NON-TKI",17913,NA,0,"","",NA,"adenocarcinoma",NA,18123,18123,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18272,2,NA,"",1,"","No Report",0,149,50,18137,NA,"Negative","Negative",0,0,1,0,14,1,"","No Prior TKI",0,"White",NA,1,"FJ34036R","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"69",0,68,"",0,1,"",0,0,"","","NON-TKI",18460,NA,0,"","",NA,"squamous",NA,18710,18654,"Durvalumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19275,2,NA,"",1,"","No Report",1,621,50,18769,NA,"Not Reported","Not Reported",0,0,0,0,115,1,"","No Prior TKI",0,"Unknown or Other",NA,1,"GL48269X","",1,1,"III",1,0,0,"",0,"",NA,NA,"","Alive",0
"70",0,65,"",1,0,"",0,0,"","","NON-TKI",18320,NA,0,"","",NA,"squamous",NA,18486,18445,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18978,2,NA,"",0,"","No Report",1,533,22,18500,NA,">=50%","90%",0,1,0,0,55,1,"","No Prior TKI",0,"Unknown or Other",NA,0,"GM27901R","",1,1,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",0
"71",0,58,"",0,1,"",0,0,"","","NON-TKI",18257,NA,0,"","",NA,"squamous",NA,18326,18305,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19180,1,NA,"",1,"","No Report",1,875,60,NA,NA,"Not Reported","Not Reported",0,0,0,1,NA,0,"","No Prior TKI",0,"White",NA,1,"HK69051T","",1,1,"III",1,0,0,"",0,"",NA,NA,"","Alive",1
